Centessa Pharmaceuticals (CNTA) Earnings Date, Estimates & Call Transcripts → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free CNTA Stock Alerts $9.08 +0.28 (+3.18%) (As of 06/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (May. 13) -$0.38 Beat By $0.03 Consensus EPS (May. 13) -$0.41 Get Centessa Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for CNTA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCNTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CNTA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Centessa Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.42)($0.42)($0.42)Q2 20241($0.41)($0.41)($0.41)Q3 20241($0.42)($0.42)($0.42)Q4 20241($0.47)($0.47)($0.47)FY 20244($1.72)($1.72)($1.72)CNTA Earnings Date and InformationCentessa Pharmaceuticals last announced its quarterly earnings results on May 13th, 2024. The reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.41) by $0.03. Centessa Pharmaceuticals has generated ($1.42) earnings per share over the last year (($1.42) diluted earnings per share). Earnings for Centessa Pharmaceuticals are expected to grow in the coming year, from ($1.76) to ($1.66) per share. Centessa Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Centessa Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Estimated)------- 5/13/2024Q1 2024($0.41)($0.38)+$0.03($0.38)--3/28/2024Q4 2023($0.44)($0.38)+$0.06($0.38)-$6.85 million11/13/2023Q3 2023($0.46)($0.40)+$0.06($0.40)--8/14/2023Q2 2023($0.43)($0.26)+$0.17($0.26)--5/12/2023Q1 2023($0.39)($0.53)($0.14)($0.53)--3/30/2023Q4 2022($0.48)($0.45)+$0.03($0.45)-- Get the Latest News and Ratings for CNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.49)($0.57)($0.08)($0.57)--8/10/2022Q2 2022($0.56)($0.69)($0.13)($0.69)--5/16/2022Q1 2022($0.69)($0.60)+$0.09($0.60)--3/30/2022Q4 2021($0.66)($0.68)($0.02)($0.68)--11/14/2021Q3 2021($0.55)($0.45)+$0.10($0.45)--8/15/2021Q2 2021($0.59)($0.65)($0.06)($0.65)-- Centessa Pharmaceuticals Earnings - Frequently Asked Questions When is Centessa Pharmaceuticals's earnings date? Centessa Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on CNTA's earnings history. Did Centessa Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.41) by $0.03. Learn more on analysts' earnings estimate vs. CNTA's actual earnings. How much revenue does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded annual revenue of $6.85 million. How much profit does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded net income of -$151.09 million. CNTA has generated -$1.42 earnings per share over the last four quarters. What is Centessa Pharmaceuticals's EPS forecast for next year? Centessa Pharmaceuticals's earnings are expected to grow from ($1.76) per share to ($1.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SRRK Earnings OCGN Earnings ALXO Earnings AGEN Earnings VTYX Earnings MCRB Earnings RPTX Earnings ACRS Earnings PBH Earnings ARWR Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:CNTA) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | Sponsored7 Great Summertime Stock Plays for YouWe’ve got seven great summertime plays for you. These stocks are in a prime position to reward your portfolio…...StockEarnings | SponsoredHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.